Dr Fátima Kranc
Investment Manager (Life Sciences)
Fátima is a Investment Manager in the Life Sciences and joined the Ventures team in 2020
Within her time at Cambridge Enterprise, she has worked with several University of Cambridge spin-out companies to develop investable propositions across Therapeutics, Life Sciences Technologies, Sustainability, AI and Drug Discovery, and Medtech.
Fátima works across all stages of the investment process from deal sourcing and due-diligence to negotiation and investment management. She supports her existing investments through strategic and operational input and currently sits on the boards of Semarion Ltd, HexagonFab Ltd, Colorifix Ltd and CamRegen Ltd.
As a keen networker, Fatima manages the engagement of national and international investors through the Cambridge Enterprise Venture Partners (CEVP) programme, and within Cambridge promotes interactions between spin-outs and Judge Business School students.
Prior to joining Cambridge Enterprise, Fátima worked for Oxford University Innovation, Cancer Research Horizons/CRUK and as Commercialisation Manager for the Babraham Institute in Cambridge. Her working career, however, started as a passionate researcher in Oxford where she held a MRC Career Development Fellowship after completing a DPhil from the Medical Sciences division also at the University of Oxford.
Fátima holds a Biology degree from the University of Porto